Ligand Pharmaceuticals
LGND
#3601
Rank
NZ$6.29 B
Marketcap
NZ$320.01
Share price
-1.93%
Change (1 day)
49.68%
Change (1 year)

Ligand Pharmaceuticals (LGND) - Total debt

Total debt on the balance sheet as of September 2025 : NZ$0.78 Billion

According to Ligand Pharmaceuticals's latest financial reports the company's total debt is NZ$0.78 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Ligand Pharmaceuticals - Total debt on balance sheet (from 1996 to 2025)

Total debt by year

Year Total debt Change
2024-12-31NZ$12.59 M29.23%
2023-12-31NZ$9.74 M-92.95%
2022-12-31NZ$0.13 B-70.9%
2021-12-31NZ$0.47 B-24.92%
2020-12-31NZ$0.63 B-34.48%
2019-12-31NZ$0.96 B1.77%
2018-12-31NZ$0.94 B200.05%
2017-12-31NZ$0.31 B2.86%
2016-12-31NZ$0.30 B4.15%
2015-12-31NZ$0.29 B18.03%
2014-12-31NZ$0.25 B2155.69%
2013-12-31NZ$11.08 M-67.75%
2012-12-31NZ$34.37 M-11.42%
2011-12-31NZ$38.8 M31.01%
2010-12-31NZ$29.61 M-40.69%
2009-12-31NZ$49.94 M-43.76%
2008-12-31NZ$88.79 M3056.31%
2007-12-31NZ$2.81 M-95.29%
2006-12-31NZ$59.72 M-76.39%
2005-12-31NZ$0.25 B3.74%
2004-12-31NZ$0.24 B-8.12%
2003-12-31NZ$0.26 B-11.72%
2002-12-31NZ$0.30 B-12.16%
2001-12-31NZ$0.34 B12.2%
2000-12-31NZ$0.30 B13.22%
1999-12-31NZ$0.26 B51.53%
1998-12-31NZ$0.17 B90.36%
1997-12-31NZ$93.39 M16.58%
1996-12-31NZ$80.11 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Amgen
AMGN
NZ$94.49 B 12,003.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
NZ$49.92 M-93.61%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$41.30 B 5,190.94%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
NZ$71.61 B 9,073.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$105.32 B 13,391.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$73.57 B 9,325.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$88.35 B 11,217.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
NZ$16.81 B 2,053.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$79.27 B 10,054.17%๐Ÿ‡บ๐Ÿ‡ธ USA